Bulletin 2010/29 - European Patent Office
Bulletin 2010/29 - European Patent Office
Bulletin 2010/29 - European Patent Office
Create successful ePaper yourself
Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.
(A61K) I.1(1)<br />
(51) A61K 36/42 (11) 2 207 559 A2*<br />
(25) Ko (26) En<br />
(21) 08842437.9 (22) 21.10.2008<br />
(84) AT BE BG CH CY CZ DE DK EE ES FI FR GB<br />
GR HR HU IE IS IT LI LT LU LV MC MT NL<br />
NO PL PT RO SE SI SK TR<br />
AL BA MK RS<br />
(86) KR 2008/006219 21.10.2008<br />
(87) WO 2009/054662 2009/18 30.04.2009<br />
(88) 11.06.2009<br />
(30) 22.10.2007 KR 20070106138<br />
(54) • WUNDHEILUNGSMITTEL MIT EINEM<br />
EXTRAKT AUS MOMORDICAE-SAMEN<br />
• WOUND-HEALING AGENT CONTAINING<br />
MOMORDICAE SEMEN EXTRACT<br />
• AGENT CICATRISANT CONTENANT UN<br />
EXTRAIT DE MOMORDICAE SEMEN<br />
(71) SK Chemicals, Co., Ltd., 600 Jeongja 1(il)dong<br />
Jangan-gu, Suwon-si, Gyeonggi-do<br />
440-300, KR<br />
(72) KIM, Bongcheol, Anyang-si Gyeonggi-do<br />
431-705, KR<br />
KIM, Joo-Hyun, Gwangju-si Gyeonggi-do<br />
464-863, KR<br />
YUN, Se Jun, Seoul 135-230, KR<br />
JANG, Gi Uk, Seoul 138-853, KR<br />
PYO, Sungsoo, Gwacheon-si Gyeonggi-do<br />
427-735, KR<br />
(74) WSL <strong>Patent</strong>anwälte, Taunusstraße 5a, 65183<br />
Wiesbaden, DE<br />
A61K 36/45 → (51) A23L 1/30<br />
A61K 36/53 → (51) A61K 31/4174<br />
A61K 36/61 → (51) A61K 31/4174<br />
A61K 36/87 → (51) A23L 1/30<br />
A61K 38/01 → (51) A61P 27/02<br />
(51) A61K 38/08 (11) 2 207 560 A2*<br />
A61P 3/00 A61P 9/00<br />
A61P 11/00 A61P 25/28<br />
A61P 31/00 A61P 35/00<br />
A61P 37/00<br />
(25) En (26) En<br />
(21) 08802380.9 (22) 09.09.2008<br />
(84) AT BE BG CH CY CZ DE DK EE ES FI FR GB<br />
GR HR HU IE IS IT LI LT LU LV MC MT NL<br />
NO PL PT RO SE SI SK TR<br />
AL BA MK RS<br />
(86) EP 2008/007867 09.09.2008<br />
(87) WO 2009/033760 2009/12 19.03.2009<br />
(88) 27.08.2009<br />
(30) 11.09.2007 EP 07017750<br />
(54) • VERWENDUNG VON FIBRONECTIN-FRAG-<br />
MENT (196-203) ALS THERAPEUTISCHES<br />
MITTEL<br />
• USE OF FIBRONECTIN FRAGMENT (196-<br />
203) AS A THERAPEUTIC AGENT<br />
• UTILISATION D'UN PEPTIDE COMME<br />
AGENT THÉRAPEUTIQUE<br />
(71) Mondobiotech Laboratories AG, Herrengasse<br />
21, 9490 Vaduz, LI<br />
(72) BEVEC, Dorian, 82110 Germering, DE<br />
CAVALLI, Fabio, CH-6925 Gentilino, CH<br />
CAVALLI, Vera, CH-6925 Gentilino, CH<br />
BACHER, Gerald, 82110 Germering, DE<br />
(74) Arth, Hans-Lothar, ABK <strong>Patent</strong> Attorneys<br />
Jasminweg 9, 14052 Berlin, DE<br />
A61K 38/08 → (51) A61K 9/10<br />
A61K 38/09 → (51) A61K 31/352<br />
A61K 38/10 → (51) A61K 9/10<br />
Europäisches <strong>Patent</strong>blatt<br />
<strong>European</strong> <strong>Patent</strong> <strong>Bulletin</strong><br />
<strong>Bulletin</strong> européen des brevets<br />
A61K 38/10 → (51) C08B 37/08<br />
(51) A61K 38/15 (11) 2 207 561 A2*<br />
A61K 31/517 A61K 31/00<br />
A61K 39/395 A61P 35/00<br />
A61P 35/02<br />
(25) En (26) En<br />
(21) 08840671.5 (22) 17.10.2008<br />
(84) AT BE BG CH CY CZ DE DK EE ES FI FR GB<br />
GR HR HU IE IS IT LI LT LU LV MC MT NL<br />
NO PL PT RO SE SI SK TR<br />
AL BA MK RS<br />
(86) US 2008/080309 17.10.2008<br />
(87) WO 2009/052379 2009/17 23.04.2009<br />
(88) 23.07.2009<br />
(30) 19.10.2007 US 981431 P<br />
(54) • VERBESSERTE ANTITUMORALE BEHAND-<br />
LUNGEN<br />
• IMPROVED ANTITUMORAL TREATMENTS<br />
• TRAITEMENTS ANTITUMORAUX AMÉLIO-<br />
RÉS<br />
(71) PHARMA MAR, S.A., Poligono Industrial La<br />
Mina-Norte Avda. de los Reyes 1 Colmenar<br />
Viejo, 28770 Colmenar Viejo (Madrid), ES<br />
ALBERT EINSTEIN COLLEGE OF MEDICINE<br />
OF YESHIVA UNIVERSITY, 1300 Morris Park<br />
Avenue Chanin Building, Bronx New York<br />
10461, US<br />
(72) PEREZ-SOLER, Roman, Bronx, New York<br />
10461, US<br />
LING, Yi-He, Bronx, New York 10461, US<br />
JIMENO DONAQUE, Jose Maria, E-28770<br />
Madrid, ES<br />
ZOU, Yi-Yu, Bronx, New York 10461, US<br />
(74) ABG <strong>Patent</strong>es, S.L., Avenida de Burgos 16D<br />
Edificio Euromor, 28036 Madrid, ES<br />
(51) A61K 38/17 (11) 2 207 562 A1*<br />
A61P 35/00<br />
(25) En (26) En<br />
(21) 08832259.9 (22) 17.09.2008<br />
(84) AT BE BG CH CY CZ DE DK EE ES FI FR GB<br />
GR HR HU IE IS IT LI LT LU LV MC MT NL<br />
NO PL PT RO SE SI SK TR<br />
AL BA MK RS<br />
(86) US 2008/010868 17.09.2008<br />
(87) WO 2009/038745 2009/13 26.03.2009<br />
(30) 18.09.2007 US 994399 P<br />
(54) • ACTIVIN-ACTRIIA-ANTAGONISTEN UND<br />
IHRE VERWENDUNGEN ZUR VERRINGE-<br />
RUNG ODER HEMMUNG DER FSH-SEK-<br />
RETION<br />
• ACTIVIN-ACTRIIA ANTAGONISTS AND<br />
USES FOR DECREASING OR INHIBITING<br />
FSH SECRETION<br />
• ANTAGONISTES DE L'ACTIVINE-ACTRIIA<br />
ET UTILISATIONS POUR RÉDUIRE OU<br />
EMPÊCHER LA SÉCRÉTION DE FSH<br />
(71) Acceleron Pharma, Inc., 128 Sidney Street,<br />
Cambridge, MA 02139, US<br />
(72) KNOPF, John, Carlisle MA 01741, US<br />
SEEHRA, Jasbir, Lexington MA 02421-6818,<br />
US<br />
SHERMAN, Matthew, L., Newton MA 02459,<br />
US<br />
(74) Lee, Nicholas John, et al, Kilburn & Strode<br />
LLP 20 Red Lion Street, London WC1R 4PJ,<br />
GB<br />
A61K 38/17 → (51) C07K 14/705<br />
A61K 38/17 → (51) C07K 14/775<br />
A61K 38/19 → (51) A61P 11/00<br />
(51) A61K 39/00 (11) 2 207 563 A1*<br />
A61K 39/395 G01N 33/53<br />
37<br />
Anmeldungen<br />
Applications<br />
Demandes (<strong>29</strong>/<strong>2010</strong>) 21.07.<strong>2010</strong><br />
C12N 5/06 C12N 5/10<br />
C12N 5/08 C12N 15/64<br />
C12P 21/06<br />
(25) En (26) En<br />
(21) 07798186.8 (22) 06.06.2007<br />
(84) AT BE BG CH CY CZ DE DK EE ES FI FR GB<br />
GR HU IE IS IT LI LT LU LV MC MT NL PL PT<br />
RO SE SI SK TR<br />
AL BA HR MK RS<br />
(86) US 2007/070542 06.06.2007<br />
(87) WO 2008/121146 2008/41 09.10.2008<br />
(30) 31.03.2007 US 909449 P<br />
(54) • PROPHYLAKTISCHER UND THERAPEUTI-<br />
SCHER IMPFSTOFF GEGEN SCHLAGAN-<br />
FALL UND NEUROLOGISCHE<br />
ERKRANKUNGEN<br />
• PREVENTIVE AND THERAPEUTIC VAC-<br />
CINE FOR STROKE AND NEUROLOGICAL<br />
DISORDERS<br />
• VACCIN POUR LA PRÉVENTION ET LE<br />
TRAITEMENT DE L'ACCIDENT VASCU-<br />
LAIRE CÉRÉBRAL ET DES TROUBLES<br />
NEUROLOGIQUES<br />
(71) Reddy, Jeeri, 6912 North 97th Circle, Suite<br />
C, Omaha NE 68122, US<br />
(72) Reddy, Jeeri, Omaha NE 68122, US<br />
(74) Lecca, Patricia S., Cabinet Lecca 21 rue de<br />
Fécamp, 75012 Paris, FR<br />
(51) A61K 39/00 (11) 2 207 564 A1*<br />
(25) En (26) En<br />
(21) 08839145.3 (22) 16.10.2008<br />
(84) AT BE BG CH CY CZ DE DK EE ES FI FR GB<br />
GR HR HU IE IS IT LI LT LU LV MC MT NL<br />
NO PL PT RO SE SI SK TR<br />
AL BA MK RS<br />
(86) US 2008/0802<strong>29</strong> 16.10.2008<br />
(87) WO 2009/052328 2009/17 23.04.2009<br />
(30) 18.10.2007 US 960893 P<br />
(54) • VERWENDUNG VON MVA ZUR BEHAND-<br />
LUNG VON PROSTATAKREBS<br />
• USE OF MVA TO TREAT PROSTATE<br />
CANCER<br />
• UTILISATION DE MVA POUR TRAITER LE<br />
CANCER DE LA PROSTATE<br />
(71) BN ImmunoTherapeutics, Inc., 2425 Garcia<br />
Avenue, Mountain View, CA 94043, US<br />
(72) DELCAYRE, Alain, San Jose CA 95124, US<br />
LAUS, Reiner, Saratoga, CA, US<br />
MANDL, Stefanie, San Francisco CA 94122,<br />
US<br />
ROUNTREE, Ryan, Blair, San Jose CA 95118,<br />
US<br />
LEGRAND, Fatema, San Carlos CA 94070,<br />
US<br />
(74) Pielken, Petra, et al, Bavarian Nordic GmbH<br />
Fraunhoferstrasse 18b, 82152 Martinsried,<br />
DE<br />
(51) A61K 39/00 (11) 2 207 565 A2*<br />
C07K 16/18<br />
(25) En (26) En<br />
(21) 08839961.3 (22) 17.10.2008<br />
(84) AT BE BG CH CY CZ DE DK EE ES FI FR GB<br />
GR HR HU IE IS IT LI LT LU LV MC MT NL<br />
NO PL PT RO SE SI SK TR<br />
AL BA MK RS<br />
(86) US 2008/080382 17.10.2008<br />
(87) WO 2009/052439 2009/17 23.04.2009<br />
(88) 04.06.2009<br />
(30) 17.10.2007 US 999423 P<br />
25.07.2008 US 83827 P<br />
(54) • AUF APOE-STATUS BASIERENDE<br />
IMMUNTHERAPIEDOSIERUNGEN<br />
• IMMUNOTHERAPY REGIMES DEPENDENT<br />
ON APOE STATUS